Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.05
XRAY's Cash to Debt is ranked higher than
50% of the 315 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.11 vs. XRAY: 0.05 )
XRAY' s 10-Year Cash to Debt Range
Min: 0.02   Max: 1.01
Current: 0.05

0.02
1.01
Equity to Asset 0.51
XRAY's Equity to Asset is ranked higher than
64% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. XRAY: 0.51 )
XRAY' s 10-Year Equity to Asset Range
Min: 0.34   Max: 0.63
Current: 0.51

0.34
0.63
Interest Coverage 8.45
XRAY's Interest Coverage is ranked higher than
60% of the 212 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.30 vs. XRAY: 8.45 )
XRAY' s 10-Year Interest Coverage Range
Min: 4.1   Max: 29.14
Current: 8.45

4.1
29.14
F-Score: 7
Z-Score: 3.42
M-Score: -2.63
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 14.73
XRAY's Operating margin (%) is ranked higher than
84% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.19 vs. XRAY: 14.73 )
XRAY' s 10-Year Operating margin (%) Range
Min: 4.25   Max: 18.58
Current: 14.73

4.25
18.58
Net-margin (%) 10.74
XRAY's Net-margin (%) is ranked higher than
83% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.12 vs. XRAY: 10.74 )
XRAY' s 10-Year Net-margin (%) Range
Min: 2.65   Max: 14.94
Current: 10.74

2.65
14.94
ROE (%) 12.86
XRAY's ROE (%) is ranked higher than
85% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.39 vs. XRAY: 12.86 )
XRAY' s 10-Year ROE (%) Range
Min: 3.38   Max: 21.51
Current: 12.86

3.38
21.51
ROA (%) 6.31
XRAY's ROA (%) is ranked higher than
81% of the 316 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.40 vs. XRAY: 6.31 )
XRAY' s 10-Year ROA (%) Range
Min: 1.74   Max: 11.68
Current: 6.31

1.74
11.68
ROC (Joel Greenblatt) (%) 35.54
XRAY's ROC (Joel Greenblatt) (%) is ranked higher than
88% of the 315 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.21 vs. XRAY: 35.54 )
XRAY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 12.14   Max: 73.99
Current: 35.54

12.14
73.99
Revenue Growth (%) 10.20
XRAY's Revenue Growth (%) is ranked higher than
83% of the 284 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.10 vs. XRAY: 10.20 )
XRAY' s 10-Year Revenue Growth (%) Range
Min: 3.8   Max: 21.5
Current: 10.2

3.8
21.5
EBITDA Growth (%) 7.10
XRAY's EBITDA Growth (%) is ranked higher than
75% of the 240 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.10 vs. XRAY: 7.10 )
XRAY' s 10-Year EBITDA Growth (%) Range
Min: -22.4   Max: 50.5
Current: 7.1

-22.4
50.5
EPS Growth (%) 5.90
XRAY's EPS Growth (%) is ranked higher than
73% of the 244 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.60 vs. XRAY: 5.90 )
XRAY' s 10-Year EPS Growth (%) Range
Min: -32.7   Max: 88.3
Current: 5.9

-32.7
88.3
» XRAY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

XRAY Guru Trades in Q3 2013

Steven Cohen 14,554 sh (New)
Chuck Royce 96,518 sh (New)
Jeremy Grantham 25,400 sh (+6.72%)
Vanguard Health Care Fund 2,285,400 sh (unchged)
Jim Simons Sold Out
Mario Gabelli 203,640 sh (-1.12%)
Robert Olstein 138,000 sh (-4.17%)
» More
Q4 2013

XRAY Guru Trades in Q4 2013

Paul Tudor Jones 17,872 sh (New)
Chuck Royce 250,318 sh (+159.35%)
Vanguard Health Care Fund 2,826,100 sh (+23.66%)
Mario Gabelli 201,040 sh (-1.28%)
Jeremy Grantham 24,100 sh (-5.12%)
Robert Olstein 113,000 sh (-18.12%)
Steven Cohen 5,503 sh (-62.19%)
» More
Q1 2014

XRAY Guru Trades in Q1 2014

Jim Simons 729,258 sh (New)
Chuck Royce 252,318 sh (+0.8%)
Vanguard Health Care Fund 2,826,100 sh (unchged)
Robert Olstein 113,000 sh (unchged)
Steven Cohen Sold Out
Jeremy Grantham Sold Out
Mario Gabelli 189,740 sh (-5.62%)
Paul Tudor Jones 12,959 sh (-27.49%)
» More
Q2 2014

XRAY Guru Trades in Q2 2014

Joel Greenblatt 72,218 sh (New)
Vanguard Health Care Fund 2,826,100 sh (unchged)
Mario Gabelli 189,740 sh (unchged)
Chuck Royce 232,588 sh (-7.82%)
Paul Tudor Jones 9,906 sh (-23.56%)
Robert Olstein 70,000 sh (-38.05%)
Jim Simons 247,658 sh (-66.04%)
» More
» Details

Insider Trades

Latest Guru Trades with XRAY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Robert Olstein 2014-06-30 Reduce -38.05%0.27%$44.34 - $48.26 $ 46.14-1%70000
Joel Greenblatt 2014-06-30 New Buy0.04%$44.34 - $48.26 $ 46.14-1%72218
Robert Olstein 2013-12-31 Reduce -18.12%0.17%$43.22 - $48.86 $ 46.14-2%113000
Vanguard Health Care Fund 2013-12-31 Add 23.66%0.08%$43.22 - $48.86 $ 46.14-2%2826100
John Keeley 2013-06-30 Sold Out 0.03%$40.24 - $44.2 $ 46.1411%0
Joel Greenblatt 2013-03-31 Sold Out 0.06%$39.59 - $43.49 $ 46.1411%0
Tom Gayner 2013-03-31 Sold Out 0.06%$39.59 - $43.49 $ 46.1411%0
Joel Greenblatt 2012-12-31 New Buy0.06%$36.17 - $40.5 $ 46.1420%24660
John Keeley 2012-03-31 Add 28.9%0.01%$35.02 - $40.19 $ 46.1429%41440
Ray Dalio 2011-12-31 Sold Out 0.25%$29.09 - $38.82 $ 46.1434%0
Jean-Marie Eveillard 2011-12-31 Sold Out 0.01%$29.09 - $38.82 $ 46.1434%0
Ray Dalio 2011-09-30 New Buy0.25%$30.86 - $39.555 $ 46.1431%550695
Meridian Funds 2011-09-30 Add 6.86%0.11%$30.86 - $39.555 $ 46.1431%1475476
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 21.10
XRAY's P/E(ttm) is ranked higher than
86% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 34.70 vs. XRAY: 21.10 )
XRAY' s 10-Year P/E(ttm) Range
Min: 12.19   Max: 116
Current: 21.1

12.19
116
P/B 2.53
XRAY's P/B is ranked higher than
69% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.99 vs. XRAY: 2.53 )
XRAY' s 10-Year P/B Range
Min: 2.07   Max: 4.65
Current: 2.53

2.07
4.65
P/S 2.26
XRAY's P/S is ranked higher than
71% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. XRAY: 2.26 )
XRAY' s 10-Year P/S Range
Min: 1.58   Max: 3.59
Current: 2.26

1.58
3.59
PFCF 16.60
XRAY's PFCF is ranked higher than
91% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 84.15 vs. XRAY: 16.60 )
XRAY' s 10-Year PFCF Range
Min: 12.39   Max: 28.2
Current: 16.6

12.39
28.2
EV-to-EBIT 18.03
XRAY's EV-to-EBIT is ranked higher than
85% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.53 vs. XRAY: 18.03 )
XRAY' s 10-Year EV-to-EBIT Range
Min: 9.8   Max: 71.7
Current: 18.03

9.8
71.7
PEG 3.37
XRAY's PEG is ranked higher than
87% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. XRAY: 3.37 )
XRAY' s 10-Year PEG Range
Min: 0.58   Max: 80.69
Current: 3.37

0.58
80.69
Shiller P/E 22.23
XRAY's Shiller P/E is ranked higher than
89% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 224.47 vs. XRAY: 22.23 )
XRAY' s 10-Year Shiller P/E Range
Min: 16.04   Max: 37.62
Current: 22.23

16.04
37.62
Current Ratio 1.37
XRAY's Current Ratio is ranked higher than
54% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.74 vs. XRAY: 1.37 )
XRAY' s 10-Year Current Ratio Range
Min: 1.2   Max: 3.9
Current: 1.37

1.2
3.9
Quick Ratio 0.86
XRAY's Quick Ratio is ranked higher than
54% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.82 vs. XRAY: 0.86 )
XRAY' s 10-Year Quick Ratio Range
Min: 0.76   Max: 2.98
Current: 0.86

0.76
2.98

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.57
XRAY's Dividend Yield is ranked lower than
77% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. XRAY: 0.57 )
XRAY' s 10-Year Dividend Yield Range
Min: 0.35   Max: 0.85
Current: 0.57

0.35
0.85
Dividend Payout 0.12
XRAY's Dividend Payout is ranked higher than
94% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. XRAY: 0.12 )
XRAY' s 10-Year Dividend Payout Range
Min: 0.05   Max: 5.67
Current: 0.12

0.05
5.67
Dividend growth (3y) 7.70
XRAY's Dividend growth (3y) is ranked higher than
76% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.70 vs. XRAY: 7.70 )
XRAY' s 10-Year Dividend growth (3y) Range
Min: 3.2   Max: 37.5
Current: 7.7

3.2
37.5
Yield on cost (5-Year) 0.79
XRAY's Yield on cost (5-Year) is ranked lower than
65% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. XRAY: 0.79 )
XRAY' s 10-Year Yield on cost (5-Year) Range
Min: 0.46   Max: 1.12
Current: 0.79

0.46
1.12
Share Buyback Rate 0.20
XRAY's Share Buyback Rate is ranked higher than
87% of the 244 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.30 vs. XRAY: 0.20 )
XRAY' s 10-Year Share Buyback Rate Range
Min: 2.2   Max: -1.3
Current: 0.2

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.12
XRAY's Price/DCF (Projected) is ranked higher than
90% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.30 vs. XRAY: 1.12 )
XRAY' s 10-Year Price/DCF (Projected) Range
Min: 0.99   Max: 2.39
Current: 1.12

0.99
2.39
Price/Median PS Value 0.95
XRAY's Price/Median PS Value is ranked higher than
77% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. XRAY: 0.95 )
XRAY' s 10-Year Price/Median PS Value Range
Min: 0.61   Max: 1.47
Current: 0.95

0.61
1.47
Price/Peter Lynch Fair Value 3.31
XRAY's Price/Peter Lynch Fair Value is ranked higher than
84% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. XRAY: 3.31 )
XRAY' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.65   Max: 11.61
Current: 3.31

0.65
11.61
Earnings Yield (Greenblatt) 5.50
XRAY's Earnings Yield (Greenblatt) is ranked higher than
75% of the 231 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. XRAY: 5.50 )
XRAY' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.4   Max: 10.2
Current: 5.5

1.4
10.2
Forward Rate of Return (Yacktman) 10.09
XRAY's Forward Rate of Return (Yacktman) is ranked higher than
82% of the 274 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.38 vs. XRAY: 10.09 )
XRAY' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -5.3   Max: 32.8
Current: 10.09

-5.3
32.8

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:DY2.Germany
DENTSPLY International, Inc., was incorporated in 1899 in Delaware. The Company is a designer, developer, manufacturer and marketer of a range of consumable dental products for the professional dental market. The Company also manufactures and markets other consumable medical device products. The Company's main product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Company conducted its business through four operating segments. All of the Company's segments are mainly engaged in the design, manufacture and distribution of dental and medical products in four principal product categories: dental consumable products; dental laboratory products; dental specialty products; and consumable medical device products. Dental consumable products consist of dental sundries and small equipment used in dental offices for the treatment of patients. The Company's dental sundry products in the dental consumable products category include dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners and topical fluoride. Dental laboratory products are used in the preparation of dental appliances by dental laboratories. The Company's products in the dental laboratory products category include dental prosthetics, including artificial teeth, precious metal dental alloys, dental ceramics and crown and bridge materials. Dental specialty products are specialized treatment products used within the dental office and laboratory settings. The Company's products in this category include endodontic (root canal) instruments and materials, implants and related products, bone grafting materials, 3D digital implantology, dental lasers and orthodontic appliances and accessories. Consumable medical device products consist mainly of urological products including catheters, certain surgical products, medical drills and other non-medical products. The Company conducts its business in the United States of America ('U.S.'), as well as in over 120 foreign countries, principally through its foreign subsidiaries. DENTSPLY has a long-established presence in the European market, particularly in Germany, Sweden, Switzerland, France, Italy and the United Kingdom as well as in Canada. The Company also has market presence in the countries of the Commonwealth of Independent States ('CIS'), Central and South America and the Pacific Rim. The Company's products are subject to regulation by, among other governmental entities, the U.S. Food and Drug Administration.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK